Atlas Trials

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Middle East

Clinical trial NCT02015286 · COMPLETED

Trial details

NCT number
NCT02015286
Sponsor
Merck KGaA, Darmstadt, Germany
Status
COMPLETED
Study type
OBSERVATIONAL
Growth Disorders
Start date
2014-03-31
Primary completion
2015-12-31
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.